Health5 hours ago
Spyre Therapeutics Launches Public Offering of Common Stock
Spyre Therapeutics, a biotechnology company listed on NASDAQ: SYRE, has initiated an underwritten public offering of its common stock. This announcement, made on October 16, 2023,...